Lopressor Medication Summary
No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication?
This medication is described in FDA/DailyMed prescribing information. No separate FDA Medication Guide was found for this label. This summary is based on FDA/DailyMed prescribing information.
What is this medication used for?
Risperidone for extended-release injectable suspension is an atypical antipsychotic indicated: for the treatment of schizophrenia. (1.1)as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of Bipolar I Disorder. (1.2)
What should I know before taking it?
Risperidone for extended-release injectable suspension is contraindicated in patients with a known hypersensitivity to either risperidone or paliperidone, or to any of the excipients in the risperidone for extended-release injectable suspension formulation. Hypersensitivity reactions, including anaphylactic reactions and angioedema, have been reported in patients treated with risperidone and in patients treated with paliperidone. Paliperidone is a metabolite of risperidone.
What important warnings are listed?
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Risperidone for extended-release injectable suspension is not approved for the treatment of patients with dementia-related psychosis. [see Warnings and Precautions (5.1)]
How is this medication usually taken?
For patients who have never taken oral RISPERDAL®, it is recommended to establish tolerability with oral RISPERDAL® prior to initiating treatment with risperidone for extended-release injectable suspension. Risperidone for extended-release injectable suspension should be administered every 2 weeks by deep intramuscular (IM) deltoid or gluteal injection. Each injection should be administered by a health care professional using the appropriate enclosed safety needle [see Dosage and Administration (2.8)]. For deltoid administration, use the 1-inch needle alternating injections between the two arms. For gluteal administration, use the 2-inch needle alternating injections between the two.
What side effects are listed?
The following are discussed in more detail in other sections of the labeling: Increased mortality in elderly patients with dementia-related psychosis[see Boxed Warning and Warnings and Precautions (5.1)] Cerebrovascular adverse events, including stroke, in elderly patients with dementia-related psychosis [see Warnings and Precautions (5.2)] Neuroleptic malignant syndrome [see Warnings and Precautions (5.3)] Tardive dyskinesia[see Warnings and Precautions (5.4)] Metabolic changes [see Warnings and Precautions (5.5)] Hyperprolactinemia [see Warnings and Precautions (5.6)] Orthostatic hypotension[see Warnings and Precautions (5.7)] Falls [see Warnings and Precautions (5.8)].
What interactions are listed?
The interactions of risperidone for extended-release injectable suspension with coadministration of other drugs have not been systematically evaluated. The drug interaction data provided in this section is based on studies with oral RISPERDAL ® .
Where can I find the official prescribing information?
Review the full prescribing information on DailyMed: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b462e48c-ef1d-4591-8fca-6b5829d8ed90
⚠️ Disclaimer
This summary is for educational purposes only and is not medical advice. Always consult your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine. Read full medical disclaimer.